Embecta (EMBC) Enterprise Value (2022 - 2026)
Embecta (EMBC) posted Enterprise Value of -$193.4 million for Q1 2026, up 5.38% sequentially from -$204.4 million in Q4 2025, and up 8.9% YoY from -$177.6 million in Q1 2025.
Embecta (EMBC) Enterprise Value (2022 - 2026) Analysis & Trends
Embecta has reported Enterprise Value for 5 years, with the latest figure at -$193.4 million in Q1 2026.
- Quarterly Enterprise Value rose 8.9% year-over-year to -$193.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$193.4 million (up 8.9% YoY) and the FY2025 annual result came in at -$228.6 million, up 16.63% from the prior year.
- Enterprise Value climbed to -$193.4 million in Q1 2026 per EMBC's latest filing, from -$204.4 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$193.4 million in Q1 2026 and troughed at -$385.2 million in Q4 2022.
- A 5-year average of -$277.2 million and a median of -$281.8 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value slumped 31.06% in 2023, then jumped 30.73% in 2025.
- Over 5 years, Enterprise Value stood at -$385.2 million in 2022, then rose by 22.46% to -$298.7 million in 2023, then advanced by 27.45% to -$216.7 million in 2024, then advanced by 5.68% to -$204.4 million in 2025, then increased by 5.38% to -$193.4 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$193.4 million, -$204.4 million, and -$228.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | -5.09 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | -863.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | -1.36 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | -1.47 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 4.83 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -403.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -138.60 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | -2.18 Bn |
| 10 | Embecta | 319.59 Mn | 101.39 Mn | 153.30 Mn | -218.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -218.20 Mn |
| Mar 31, 2026 | -193.40 Mn |
| Dec 31, 2025 | -204.40 Mn |
| Sep 30, 2025 | -228.60 Mn |
| Jun 30, 2025 | -233.60 Mn |
| Mar 31, 2025 | -212.30 Mn |
| Dec 31, 2024 | -216.70 Mn |
| Sep 30, 2024 | -274.20 Mn |
| Jun 30, 2024 | -281.80 Mn |
| Mar 31, 2024 | -306.50 Mn |
| Dec 31, 2023 | -298.70 Mn |
| Sep 30, 2023 | -326.50 Mn |
| Jun 30, 2023 | -317.40 Mn |
| Mar 31, 2023 | -346.40 Mn |
| Dec 31, 2022 | -385.20 Mn |
| Sep 30, 2022 | -330.90 Mn |
| Jun 30, 2022 | -292.30 Mn |
| Mar 31, 2022 | -264.30 Mn |